Solid Biosciences Announces Stockholder Approval Of Acquisition Of Aavantibio
Acquiring Company
Solid Biosciences
Acquired Company
AavantiBio, Inc.
MassachusettsGainesvilleBiotechnologyHealthcareHealth CareGeneticsTherapeuticsBiotechnologyHealth CareGeneticsTherapeuticsDescription
Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the results of the special meeting of the stockholders held on December 1, 2022. At the special meeting, Solid’s stockholders voted in favor of all proposals, including the proposal to issue shares of Solid’s common stock to stockholders of AavantiBio in connection with the acquisition of AavantiBio pursuant to the agreement and plan of merger dated September 29, 2022 (the “Merger Agreement”) and to certain institutional investors in connection with a concurrent $75 million private placement. AavantiBio, Inc. is a privately held gene therapy company focused on transforming the lives of patients with Friedreich’s ataxia and rare cardiomyopathies.
Fundz sees it the moment Solid Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired AavantiBio, Inc.?
AavantiBio, Inc. was acquired by Solid Biosciences, based in Massachusetts. The deal was reported on December 1, 2022. Solid Biosciences is publicly traded (SLDB) and operates in Biotechnology.
When did Solid Biosciences acquire AavantiBio, Inc.?
Solid Biosciences's acquisition of AavantiBio, Inc. was reported on December 1, 2022. Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the results of the special meeting of the stockholders held on December 1, 2022. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does AavantiBio, Inc. do?
It is privately held, operating in Biotechnology, and is based in Gainesville.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.